New insights into the distribution of APOE polymorphism in the Iberian Peninsula. The case of Andalusia (Spain)

References

• Abboud S, Viiri LE, Lütjohann D, Goebeler S, Luoto T, Friedrichs S, Desfontaines P, et al. 2008. Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. Eur J Hum Genet 16:955–960
   PubMedGoogle Scholar
• Allan CM, Walker D, Segrest JP, Taylor JM. 1995. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics 28:291–300
   PubMed Web of Science ®Google Scholar
• Ambrosio B, Dugoujon JM, Hernández C, De La Fuente D, González-Martín A, Fortes-Lima CA, Novelletto A, et al. 2010a. The Andalusian population from Huelva reveals a high diversification of Y-DNA paternal lineages from haplogroup E: identifying human male movements within the Mediterranean space. Ann Hum Biol 37:86–107
   PubMed Web of Science ®Google Scholar
• Ambrosio B, Hernández C, Novelletto A, Dugoujon JM, Rodríguez JN, Cuesta P, Fortes-Lima C, Calderón R. 2010b. Searching the peopling of the Iberian Peninsula from the perspective of two andalusian subpopulations: a study based on Y-chromosome haplogroups J and E. Coll Antropol 34:1215–1228
   PubMedGoogle Scholar
• Barbagallo CM, Polizzi F, Severino M, Rizzo M, Vivona N, Onorato F, Caldarella R, et al. 2001. ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size. Eur J Epidemiol 17:707–713
   PubMed Web of Science ®Google Scholar
• Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, et al. 2007. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298:1300–1311
   PubMed Web of Science ®Google Scholar
• Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S. 1999. Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol Dis 6:508–514
   PubMedGoogle Scholar
• Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, et al. 2008. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA 105:8718–8723
   PubMed Web of Science ®Google Scholar
• Corbo RM, Scacchi R. 1999. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a “thrifty” allele? Ann Hum Genet 63:301–310
   PubMed Web of Science ®Google Scholar
• Corder E, Saunders A. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923
   PubMed Web of Science ®Google Scholar
• Davignon J, Gregg RE, Sing CF. 1988. Review apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8:1–21
   PubMedGoogle Scholar
• De Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM. 1994. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 4:178–194
   PubMed Web of Science ®Google Scholar
• Eisenberg DT, Kuzawa CW, Hayes MG. 2010. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143:100–111
   PubMed Web of Science ®Google Scholar
• Excoffier L, Lischer HEL. 2010. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10:564–567
   PubMed Web of Science ®Google Scholar
• Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, et al. 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356
   PubMed Web of Science ®Google Scholar
• Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, et al. 2001. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology 57:853–857
   PubMed Web of Science ®Google Scholar
• Federoff M, Jimenez-Rolando B, Nalls MA, Singleton AB. 2012. A large study reveals no association between APOE and Parkinson’s disease. Neurobiol Dis 46:389–392
   PubMedGoogle Scholar
• Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengârd JH, Salomaa V, et al. 2000. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67:881–900
   PubMed Web of Science ®Google Scholar
• Garcés C, Cantos M, Benavente M, Granizo JJ, Cano B, Viturro E, De Oya M. 2004. Variations in APOE genotype distribution in children from areas with different adult cardiovascular disease mortality in Spain. Hum Biol 76:615–621
   PubMedGoogle Scholar
• Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O. 1996. Are men carrying the apolipoprotein epsilon 4- or epsilon 2 allele less fertile than epsilon 3 epsilon 3 genotypes? Hum Genet 98:239–242
   PubMedGoogle Scholar
• Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. 2000. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a “frailty gene,” not a “longevity gene”. Genet Epidemiol 19:202–210
   PubMed Web of Science ®Google Scholar
• Gómez-Coronado D, Alvarez JJ, Entrala A, Olmos JM, Herrera E, Lasunción MA. 1999. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 147:167–176
   PubMedGoogle Scholar
• Haddy N, De Bacquer D, Chemaly MM, Maurice M, Ehnholm C, Evans A, Sans S, et al. 2002. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 10:841–850
   PubMed Web of Science ®Google Scholar
• Hanlon CS, Rubinsztein DC. 1995. Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112:85–90
   PubMed Web of Science ®Google Scholar
• Harich N, Esteban E, López-Alomar A, Chafik A, Moral P. 2002. Apolipoprotein molecular variation in Moroccan Berbers: pentanucleotide (TTTTA)n repeat in the LPA gene and APOE-C1-C2 gene cluster. Clin Genet 62:240–244
   PubMedGoogle Scholar
• Hernández CL, Reales G, Dugoujon JM, Novelletto A, Rodriguez JN, Cuesta P, Calderón R. 2014. Human maternal heritage in Andalusia (Spain): its composition reveals high internal complexity and distintive influences of mtDNA haplogroups U6 and L in the western and eastern side of region. BMC Genet 15:11. doi: 10.1186/1471-2156-15-11
   Google Scholar
• Huang Y, Weisgraber KH, Mucke L, Mahley RW. 2004. Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer’s disease. J Mol Neurosci 23:189–204
   PubMed Web of Science ®Google Scholar
• Hui DY, Innerarity TL, Mahley RW. 1984. Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E. J Biol Chem 259:860–869
   PubMedGoogle Scholar
• Kuhlmann I, Minihane AM, Huebbe P, Nebel A, Rimbach G. 2010. Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. Lipids Health Dis 9:8 . doi: 10.1186/1476-511X-9-8
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Doppler V, Beucler I, Costes G, Salachas F, Raisonnier A, Le Forestier N, et al. 2002. APOE: a potential marker of disease progression in ALS. Neurology 58:1112–1114
   PubMed Web of Science ®Google Scholar
• Lao O, Dupanloup I, Barbujani G, Bertranpetit J, Calafell F. 2008. The Mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics. Ann Hum Genet 72:48–56
   PubMedGoogle Scholar
• Lebart L, Morineau A, Warwick KM. 1984. Multivariate descriptive statistical analysis: correspondence analysis and related techniques for large matrices. New York: Wiley
   Google Scholar
• Lee JH, Tang MX, Schupf N, Stern Y, Jacobs DM, Tycko B, Mayeux R. 2001. Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 103:121–127
   PubMed Web of Science ®Google Scholar
• Lehtimäki T, Moilanen T, Viikari J, Akerblom HK, Ehnholm C, Rönnemaa T, Marniemi J, et al. 1990. Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. J Lipid Res 31:487–495
   PubMed Web of Science ®Google Scholar
• Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622–630
   PubMed Web of Science ®Google Scholar
• Mahley RW, Rall SCJ. 2000. Apolipoprotein E: far more than a lipid transport protein. Ann Rev Genom Hum Genet 1:507–537
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y. 2006. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer’s disease. Proc Natl Acad Sci USA 103:5644–5651
   PubMed Web of Science ®Google Scholar
• Martinez M, Brice A, Vaughan JR, Zimprich A, Breteler MMB, Meco G, Filla A, et al. 2005. Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson’s disease. Am J Med Genet B Neuropsychiatr Genet 136B:72–74
   PubMedGoogle Scholar
• Mastana SS, Calderon R, Pena J, Reddy PH, Papiha SS. 1998. Anthropology of the apoplipoprotein E (apo E) gene: low frequency of apo E4 allele in Basques and in tribal (Baiga) populations of India. Ann Hum Biol 25:137–143
   PubMed Web of Science ®Google Scholar
• Mitchell R, Kumar V, Abbas A, Fausto N. 2007. Basic pathology. 8th ed. Philadelphia, PA: Elsevier
   Google Scholar
• Nebel A, Kleindorp R, Caliebe A, Nothnagel M, Blanché H, Junge O, Wittig M, et al. 2011. A genome-wide association study confirms APOE as the major gene influencing survival in long-lived individuals. Mech Ageing Dev 132:324–330
   PubMed Web of Science ®Google Scholar
• Neel JV. 1962. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am J Hum Genet 14:353–362
   PubMed Web of Science ®Google Scholar
• Pulkes T, Papsing C, Mahasirimongkol S, Busabaratana M, Kulkantrakorn K, Tiamkao S. 2011. Association between apolipoprotein E genotypes and Parkinson’s disease. J Clin Neurosci 18:1333–1335
   PubMedGoogle Scholar
• Rall SC, Weisgraber KH, Mahley RW. 1982. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem 257:4171–4178
   PubMed Web of Science ®Google Scholar
• Scacchi R, Corbo RM, Rickards O, Mantuano E, Guevara A, De Stefano GF. 1997. Apolipoprotein B and E genetic polymorphisms in the Cayapa Indians of Ecuador. Hum Biol 69:375–382
   PubMed Web of Science ®Google Scholar
• Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. 1994. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6:29–32
   PubMed Web of Science ®Google Scholar
• Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, et al. 2000. Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis 152:475–488
   PubMed Web of Science ®Google Scholar
• Schupf N, Barral S, Perls T, Newman A, Christensen K, Thyagarajan B, Province M, et al. 2012. Apolipoprotein E and familial longevity. Neurobiol Aging 34:1287–1291
   PubMedGoogle Scholar
• Singh PP, Singh M, Mastana SS. 2006. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33:279–308
   PubMed Web of Science ®Google Scholar
• Song Y, Stampfer MJ, Liu S. 2004. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141:137–147
   PubMed Web of Science ®Google Scholar
• Teoh CL, Griffin MDW, Howlett GJ. 2011. Apolipoproteins and amyloid fibril formation in atherosclerosis. Protein Cell 2:116–127
   PubMedGoogle Scholar
• Utermann G, Langenbeck U, Beisiegel U, Weber W. 1980. Genetics of the apolipoprotein E system in man. Am J Hum Genet 32:339–347
   PubMed Web of Science ®Google Scholar
• Van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. 1994. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nat Genet 7:74–78
   PubMed Web of Science ®Google Scholar
• Vitek MP, Brown CM, Colton CA. 2010. APOE genotype-specific differences in the innate immune response. Neurobiol Aging 30:1350–1360
   Google Scholar
• Weisgraber KH, Mahley RW. 1996. Human apolipoprotein E: the Alzheimer’s disease connection. FASEB J 10:1485–1494
   PubMed Web of Science ®Google Scholar
• Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. 1996. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol 16:1250–1255
   PubMed Web of Science ®Google Scholar
• Zannis VI, Breslow JL, Utermann G, Mahley RW, Weisgraber KH, Havel RJ, Goldstein JL, et al. 1982. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res 23:911–914
   PubMed Web of Science ®Google Scholar